Synthelis Biotech Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 1

Synthelis Biotech General Information

Description

Developer of protein targets designed to assist the development of vaccines, biologics, enzymes, engineered proteins, diagnostic tools, and high-throughput molecule or ligand screening. The company's proprietary cell-free expression technology opens new socio-economic horizons for the development and production of innovative health products by designing biomolecules for pharmaceutical, biomedical, and biotechnological research organizations and academic laboratories, enabling medicine developers to assist with structural and functional/electrophysiological studies.

Contact Information

Formerly Known As
Synthelis
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 5, Avenue du Grand Sablon
  • La Tronche
  • 38700 Grenoble
  • France
+33 04
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5, Avenue du Grand Sablon
  • La Tronche
  • 38700 Grenoble
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthelis Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC Cancelled Generating Revenue
6. Angel (individual) 01-Jan-2024 Completed Generating Revenue
5. Grant 01-Jan-2024 Completed Generating Revenue
4. Merger/Acquisition 24-Nov-2023 Completed Generating Revenue
3. Later Stage VC 23-Jun-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 21-Jan-2014 $942K $942K Completed Generating Revenue
1. Accelerator/Incubator 10-Jan-2011 Completed Generating Revenue
To view Synthelis Biotech’s complete valuation and funding history, request access »

Synthelis Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P
P
O 14,579 $1.125645
To view Synthelis Biotech’s complete cap table history, request access »

Synthelis Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of protein targets designed to assist the development of vaccines, biologics, enzymes, engineered proteins, di
Pharmaceuticals
Grenoble, France
8 As of 2024

Ann Arbor, MI
 

Monheim, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synthelis Biotech Competitors (3)

One of Synthelis Biotech’s 3 competitors is Daicel Arbor Biosciences, a Formerly Accelerator/Incubator backed company based in Ann Arbor, MI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Daicel Arbor Biosciences Formerly Accelerator/Incubator backed Ann Arbor, MI
Cube Biotech Private Equity-Backed Monheim, Germany
Vaxcyte Formerly VC-backed San Carlos, CA
You’re viewing 3 of 3 competitors. Get the full list »

Synthelis Biotech Patents

Synthelis Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100189774-A1 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system Active 26-Apr-2007
US-9206456-B2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system Active 26-Apr-2007

Synthelis Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synthelis Biotech Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alpes Capital Innovation Venture Capital Minority
Banque Populaire Auvergne Rhône Alpes Corporation Minority
Celertis Finance Corporation Minority
Crédit Agricole Alpes Développement PE/Buyout Minority
Crédit Agricole Sud Rhône Alpes Lender/Debt Provider Minority
You’re viewing 5 of 13 investors. Get the full list »

Synthelis Biotech FAQs

  • When was Synthelis Biotech founded?

    Synthelis Biotech was founded in 2011.

  • Where is Synthelis Biotech headquartered?

    Synthelis Biotech is headquartered in Grenoble, France.

  • What is the size of Synthelis Biotech?

    Synthelis Biotech has 8 total employees.

  • What industry is Synthelis Biotech in?

    Synthelis Biotech’s primary industry is Pharmaceuticals.

  • Is Synthelis Biotech a private or public company?

    Synthelis Biotech is a Private company.

  • What is Synthelis Biotech’s current revenue?

    The current revenue for Synthelis Biotech is .

  • How much funding has Synthelis Biotech raised over time?

    Synthelis Biotech has raised $469K.

  • Who are Synthelis Biotech’s investors?

    Alpes Capital Innovation, Banque Populaire Auvergne Rhône Alpes, Celertis Finance, Crédit Agricole Alpes Développement, and Crédit Agricole Sud Rhône Alpes are 5 of 13 investors who have invested in Synthelis Biotech.

  • Who are Synthelis Biotech’s competitors?

    Daicel Arbor Biosciences, Cube Biotech, and Vaxcyte are competitors of Synthelis Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process